XXV European Congress on Perinatal Medicine 2016
 

DAY 1 - Wednesday June 15th

18.00 - 19.30

AUDITORIUM 1 + 2
OPENING CEREMONY

Chairpersons: U. Simeoni (Switzerland); J. Nijhuis (The Netherlands)

18.00 - 18.05

Welcome from Maastrich Major

18.05 - 18.10

U. Simeoni (Switzerland)
Welcome of the EAPM President

18.10 - 18.20

J.G. Nijhuis (The Netherlands); L. Zimmermann (The Netherlands)
Welcome of the ECPM Local Committee

18.20 - 19.00

D. Bianchi (USA)
How to discover fetal treatments with 20,000+ genes  and 1000s of developing pathways: Down syndrome as an example

19.00 - 21.00

EXHIBITION AREA
WELCOME RECEPTION
- Admission by badge only

 

DAY 2 - Thursday June 16th

08.00 - 08.55

5 PARALLEL ROOMS - ORAL PRESENTATION SESSIONS

08.00 - 08.55

AUDITORIUM 2
ORAL COMMUNICATION TH1.A
- ABNORMAL PLACENTATION

Chairperson: M. Spaanderman (The Netherlands)

ULTRASONOGRAPHIC AND PATHOLOGICAL DIAGNOSTIC CORRELATIONS IN ABNORMAL PLACENTATION
C. Berceanu; E. Brătilă; S. Vlădăreanu; M. M. Cîrstoiu; C. Simionescu; V. Gheorman;  R. Ciortea; C. Mehedin
țu; S. Berceanu

PREVALENCE OF PLACENTAL INSUFFICIENCY COMPLICATIONS ON OOCYTE DONATION PREGNANCIES
O. Villar; L. Álvaro; C. Villalaín; R. Bermejo; I. Herráiz; E. Gómez-Montes

IMPACT OF RISK FACTORS IN SPECIFIC AREAS OF BEHAVIORAL DEVELOPMENT IN MONOCHORIONIC HEALTHY TWINS INVESTIGATED WITH GRIFFITHS’ SCALE
A. La Verde; M. Balestriero; B. Scelsa; C. Colombo; V. Brazzoduro; P. Introvini; E. Mascheroni; C. Ionio; M. Rustico; M. Mastrangelo; G. Lista

PLACENTA ASSOCIATED PREGNANCY COMPLICATIONS IN PREGNANCIES COMPLICATED WITH PLACENTA PREVIA
Y. Baumfeld; R. Herkovitz ; Z. Bar Niv; A.Y. Weintraub

THE ROLE OF DECIDUAL NATURAL KILLER CELLS IN RECURRENT MISSED ABORTIONS
D. Radovic Janosevic;  D. Krtinic; A. Tubic Pavlovic; J. Milosevic Stevanovic; M. Tasic;  S. Pop-Trajkovic Dinic

08.00 - 08.55

0.4 BRUSSELS
ORAL COMMUNICATION TH1.B
- INFECTION AND SURROUNDINGS 1

Chairperson: B. Kramer (The Netherlands)

ALTERED GENTAMICIN PHARMACOKINETICS IN NEONATES UNDERGOING CONTROLLED HYPOTHERMIA
Y. Bijleveld; T. de Haan; J. van der Lee; F. Groenendaal; P. Dijk;A. van Heijst; R. de Jonge; K. Dijkman; H. van Straaten; M. Rijken; I. Zonnenberg; F. Cools; A. Zecic; D. Nuyteman; A. van Kaam; R. Mathot

GROUP B STREPTOCOCCUS COLONIZATION IN OBESE AND DIABETIC PREGNANT WOMEN
G. Moreno Coca; M.J. Canto Rivera; S. Palmero Aliste; M. Esteve Martinez; M. Pérez de Puig; F. Ojeda Pérez

IS CHORIOAMNIONITIS A RISK OR A PROTECTIVE FACTOR FOR PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTS? A SYSTEMATIC REVIEW AND META-ANALYSIS
E. Villamor; E. Behbodi; E. Villamor-Martínez; P.L. J. Degraeuwe

HAND HYGIENE IN REDUCING BLOODSTREAM INFECTION RATE IN NEONATAL UNIT OF CIPTO MANGUNKUSUMO HOSPITAL INDONESIA
T.N. Paramita; R. Rohsiswatmo

RISK FACTORS ASSOCIATED WITH HEARING LOSS AND NEUROLOGIC IMPAIRMENT IN THE SPANISH NETWORK OF INFANTS WITH CONGENITAL CYTOMEGALOVIRUS INFECTION (REDICCMV)
L. Castells Vilella; R. Díez; J. Vilas; I. Olabarrieta; A. Medina; P. Galán; A.M. Grande; O. Calavia; J. Beceiro; A. Filgueira; I. Llana; E. Colino; B. Agúndez; J. Barja; M. Llorente; P. Terol; D. Blázquez-Gamero and REDICCMV Study Group

08.00 - 08.55

0.5 PARIS
ORAL COMMUNICATION TH1.C
- INTRAPARTUM SURVEILLANCE 1

Chairperson: W. Gyselaers (Belgium)

COMPUTERISED ANTEPARTUM FETAL MONITORING UPDATED: THE NEW DAWES-REDMAN 2016 SYSTEM
C.W.G. Redman; P. Szafranski; A. Georgieva

FETAL LACTATE SENSOR
P. P. van den Berg; T. Cremers

ST EVENTS REDEFINED:  CUT OFF FOR RELATIVE ST ANALYSIS
A.D.J. Hulsenboom;  M.B. van der Hout-van der Jagt; R.Vullings; A. Kwee; J.O.E.H. van Laar; S.G. Oei

REDUCED INCIDENCE OF CORD METABOLIC ACIDOSIS USING ST-ANALYSIS OF THE FETAL ELECTROCARDIOGRAM FOR INTRAPARTUM SURVEILLANCE
A. Landman; S. Immink-Duijker; E. Mulder; W. Koster; S. Xodo; G. Visser; F. Groenendaal ; A. Kwee

A DATA-DRIVEN SYSTEM FOR CONTINUOUS FETAL MONIOTRING IN LABOUR: THE OXFORD PROTOTYPE
A. Georgieva; A. Papageorghiou; C.W.G. Redman

08.00 - 08.55

0.2/0.3 BERLIN/COPENHAGEN
ORAL COMMUNICATION TH1.
D - THE PRETERM INFANT 1

Chairperson: T. Orlikowsky (Germany)

DOPAMINE AND NS IN TREATMENT FOR ARTERIAL HYPOTENSION IN ELBW
D Kryuchko; E Baibarina; E. Balashova; A. Kirtbaya; O. Ionov

PREDICTING FACTORS OF RESISTANCE TO IBUPROFEN FOR TREATMENT OF PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTS
G. Kongolo; C. Chazal;  S. Goudjil; E. Carpentier; L. Razafimanantsoa; F. Moreau; A. Leke

LATE PRETERM BIRTH HAS DIRECT AND INDIRECT EFFECTS ON GUT MICROBIOTA DEVELOPMENT DURING THE FIRST 6 MONTHS OF LIFE
M. Forsgren; E. Isolauri; T. Poussa; S. Salminen; S. Rautava

DEVELOPMENT OF INTESTINAL MICROBIOTA IN VERY PRETERM INFANTS
R. Ambrosino; E. Martín Álvarez; A.M. Gil Fenoy; J.A. Maldonado Lobon; A.D. Valero; J.A. Hurtado Suazo

ASSOCIATION BETWEEN THE P.THR1406ASN POLYMORPHISM OF THE CARBAMOYL-PHOSPHATE SYNTHETASE 1 GENE AND NECROTIZING ENTEROCOLITIS: A PROSPECTIVE MULTICENTER STUDY
R. M. Moonen; G. Cavallaro; M. J. Huizing; G. E. González-Luis4; F. Mosca; E. Villamor

08.00 - 08.55

0.11 PRESS ROOM
ORAL COMMUNICATION TH1.E
- CORD ACID-BASE BALANCE

Chairperson: P. Gressens

EARLY  OUTCOME OF NEONATES WITH UMBILICAL CORD BLOOD ACIDEMIA (PH<7.1)
T. Smolkin; S. Ravid; I. Ulanovsky; A. Ilivitzki; T. Mashiach; I. Makhoul

UMBILICAL CORD BLOOD BASE DEFICIT PREDICTS THE DEVELOPMENT OF SIGNIFICANT HYPERBILIRUBINEMIA IN HEALTHY TERM AND NEAR-TERM NEWBORNS
K.A. Simbi

UMBILICAL ARTERIAL PH ≤ 7.00 AND BASE EXCESS > -12. IS IT AN ACCEPTABLE DEFINITION OF PATHOLOGICAL FETAL ACIDEMIA?
S. Martí Gamboa; J. Pascual Mancho; M. Lapresta Moros; O. Redrado Giménez; J.  Ruiz Sada; M. Rodrigo Rodríguez; L. Rodríguez Lázaro; S. Castán Mateo

VASOMOTOR EFFECTS OF HYDROGEN SULFIDE IN HUMAN UMBILICAL VESSELS
E. Villamor; R. Mohammed; L. Provitera; G. Cavallaro; F. Mosca

PH, BASE EXCESS OR LACTATE. WHICH IS BETTER FOR PREDICTING NEONATAL MORBIDITY?
S. Martí Gamboa; J. Pascual Mancho; M. Lapresta Moros; O. Redrado Giménez; J.  Ruiz Sada; M. Rodrigo Rodríguez; L. Rodríguez Lázaro; S. Castán Mateo

09.00 - 09.30

AUDITORIUM 1 + 2
KEY NOTE LECTURE

Chairperson: L. Zimmermann (The Netherlands)

P. Hüppi (Switzerland)
Prematurity and IUGR: Common brain consequences

09.30 -10.30

AUDITORIUM 1
SEMI PLENARY 1:
PLM8) MATERNAL OBESITY AND METABOLIC SYNDROME

Chairpersons: G. H. Visser (The Netherlands); A. Syngelaki (UK)

09.30 - 10.00

I. Cetin (Italy)
Placental function and fetal growth in maternal obesity

10.00 - 10.30

J. Stupin (Germany)
Perinatal programming of obesity

9.30 -10.30

AUDITORIUM 2
SEMI PLENARY 2:
DPL-NEO3) MICROBIOTA

Chairpersons: I. Reiss (the Netherlands) ; C. Speer (Germany)

9.30 - 10.00

E. Isolauri (Findland)
Microbiota hypothesis: impact of the development of gut microbiota

10.00 - 10.30

P.H.M. Savelkoul (The Netherlands)
Early detection of necrotizing enterocolitis (NEC) by intestinal microbiota composition

10.30 - 11.00

COFFEE BREAK AND POSTER VIEWING
TOPIC:
MISCELLANEOUS

 

11.00 - 12.30

AUDITORIUM 1
PARALLEL 1:
NEONATAL INFECTIONS

Chairpersons: R. Kornelisse (The Netherlands) ; Erika Isolauri (Finland)

11.00 - 11.18

R. M. Van Elburg (The Netherlands)
Neonatal infections and long-term outcomes 

11.18 - 11.36

R. Kornelisse (The Netherlands)
Prevention of hospital acquired infections

11.36 - 11.54

C. P. Speer (Germany)
Ureaplasma species and newborn morbidities

11.54 - 12.12

T. Orlikowsky (Germany)
Candida Infection in Preterms

12.12 - 12.30

G. Nigro (Italy)
Prenatal and postnatal therapy of congenital cytomegalovirus infection

11.00 - 12.30

AUDITORIUM 2
PARALLEL 2:
THUR PAR-M1) SYMPOSIUM FETAL ALCOHOL SPECTRUM DISORDERS: PREVENTION AND MANAGEMENT

Chairpersons:J. Nijhuis (The Netherlands); L. Curfs (The Netherlands)

11.00 - 11.10

L. M. G. Curfs (The Netherlands)
Introduction into the topic

11.10 - 11.30

S. Roozen (The Netherlands)
Alcohol consumption during pregnancy: worldwide prevalence of Fetal Alcohol Spectrum Disorders (FASD)

11.30 - 11.50

L. Olivier (South Africa)
Fetal Alcohol Spectrum Disorders: planning health prevention programs

11.50 - 12.10

G. Kok (The Netherlands)
FASD prevention warranted; implications for interventions

12.10 - 12.30

General discussion lead by Prof. dr. J. Nijhuis

11.00 - 12.30

0.4/0.5 BRUSSELS/PARIS
PARALLEL 3:
THUR PAR-M3) PRETERM NEUROPROTECTION

Chairpersons: L. Hellström-Westas (Sweden) - F. van Bel (the Netherlands)

11.00 - 11.20

F. Van Bel (The Netherlands)
Prevention of Brain injury in the preterm infant

11.20 - 11.40

P. Gressens (France)
Melatonin for neonatal neuroprotection

11.40 - 12.00

P. Hüppi (Switzerland) 
Epo to protect the preterm brain

12.00 - 12.20

G. Van Wassenaer (The Netherlands)
Postnatal interventions to improve outcomes in high-risk preterm infants

12.20 - 12.30

Discussion

11.00 - 12.30

0.2/0.3 BERLIN/COPENHAGEN
PARALLEL 4:
THUR PAR-OB3) PREECLAMPSIA

Chairpersons: J. Stupin (Germany); J. Cornette (The Netherlands)

11.00 - 11.18

B. Thilaganathan (UK)
Types of early and late onset preeclampsia: an integrated model

11.18 - 11.36

J. Cornette (The Netherlands)
Short & long term cardiovascular outcome after preeclampsia

11.36 - 11.54

M. Spaanderman (The Netherlands)
Evaluating risk for repeated preeclampsia/HELLP (the Pre Care Study)

11.54 - 12.12

H. Valensise (Italy)
Therapeutic manipulation of vascular resistance in IUGR/PET

12.12 - 12.30

L. Poon (UK)
Aspirin for preventing preeclampsia

11.00 - 12.30

0.11 PRESS ROOM
PARALLEL 5:
THUR PAR-NEO2) NON-INVASIVE VENTILATION

Chairpersons: C.C. Roehr (UK) ; R. Ballard (USA)

11.00 - 11.20

A. Kribs (Germany)
Minimal (pulmonary) handling in the delivery room

11.20 - 11.40

G. Lista (Italy)
Sustained lung inflation

11.40 - 12.00

C.C. Roehr (UK)
Rationale of non-invasive ventilation

12.00 - 12.20

M. Sanchez Luna (Spain)
Non-invasive ventilation in preterm infants

12.20 - 12.30

Discussion

12.30 - 13.30

EXHIBITION & POSTER VIEWING

12.30 - 13.30

0.4/0.5 BRUSSELS/PARIS
SPONSORED LUNCHEON SYMPOSIUM
*see sponsored sessions

13.30 - 15.00

AUDITORIUM 1
PARALLEL 1:
MOTHER AND NEWBORN HOSPITALS OF THE FUTURE - EFCNI

Chairpersons: Silke Mader (Germany); B. Hallberg (Sweden)

13.30 - 14.00

B. Hallberg (Sweden)
Rebuilding a mother and child hospital: challenges and opportunities

14.00 - 14.30

T. Mohns (The Netherlands)
Implementing family centered private room in the NICU

14.30 - 15.00

L. Lehtonen (Finland)
Developing close collaboration between parents and staff - how to change our daily routine?

13.30 - 15.00

AUDITORIUM 2
PARALLEL 2:
THUR PAR-M2) FETAL GROWTH RESTRICTION/IUGR

Chairpersons: H. Valensise (Italy); E.Gratacos (Spain)

13.30 - 14.00

E. Gratacos (Spain)
Stage based management of IUGR

14.00 - 14.30

A. L. David (UK)
VEGF gene therapy for severe IUGR

14.30 - 15.00

C. Lees (UK)
Fetal ductus venosus Doppler waveform and infant outcomes

13.30 - 15.00

0.4/0.5 BRUSSELS/PARIS
PARALLEL 3: NORTH-EAST EUROPE PERINATAL SESSION

Chairpersons: Anton Mikhailov (Russia); Dmitry Ivanov (Russia) 

13.30 - 13.40

G. Sukhikh (Russia)
Cellular biology and perinatal medicine

13.40 - 13.50

N.Veropotvelyan (Ukraine)
Hereditary thrombophilia - prenatal manifestation and care at different stages of in pregnancy

13.50 - 14.00

V. Radzinsky (Russia)
New approach of CS for safety in very preterm deliveries

14.00 - 14.10

A. Mikhelson (Russia)
Past and future of “near miss” patients

14.10 - 14.20

F. Szirko (Estonia)
Quality assurance of deliveries with low pH newborns

14.20 - 14.30

A. Liubsys (Lithuania)
Late preterm infant: problems and challenges

14.30 - 14.40

I. Soldatova (Russia)
Normal human immunoglobulin efficacy in preventing mortality in adults, newborns and older children with bacterial infections and sepsis

14.40 - 14.50

R. Shmakov (Russia)
Cancer and pregnancy - treatment strategy, perinatal care and outcomes

14.50 - 15.00

Discussion

13.30 - 15.00

0.2/0.3 BERLIN/COPENHAGEN
PARALLEL 4:
THUR PAR-OB1) PREGNANCIES AND DELIVERIES IN MIGRANT WOMEN

Chairpersons: J. Zeitlin (France) J. Derks (the Netherlands)

13.30 - 14.00

J. Zeitlin (France)
Migration to western industrialized countries and perinatal health

14.00 - 14.30

B. Essén (Sweden)
Suboptimal care and maternal mortality among foreign-born women in Sweden

14.30 - 15.00

D. Ayres-de-Campos (Portugal)
Obstetric care in a migrant population with free access to health care

13.30 - 15.00

0.11 PRESS ROOM
PARALLEL 5:
THUR PAR-NEO1) NEONATAL INFLAMMATORY DISEASES

Chairpersons: GL Lista (Italy) ; R. Ballard (USA)

13.30 - 14.00

B. W. Kramer (The Netherlands)
Effects of chorioamnionitis on the fetus and newborn

14.00 - 14.30

A.W.D. Gavilanes (The Netherlands)
Early-onset neuroinflammation and impaired long-term outcome

14.30 - 15.00

P. Ballard (USA)
Corticosteroid Therapy for Infant Lung Disease

15.00 - 16.30

AUDITORIUM 1
SEMI-PLENARY 1: DPL-OB1) DIABETES AND PREGNANCY- INVENTIONS & INNOVATIONS

Chairpersons: D. Ayres-de-Campos (Portugal); R. C. Berg (Norway)

15.00 - 15.20

O. Koren (Israel)
Perinatal programming of GDM – the role of maternal Microbiome

15.20 - 15.40

A. Syngelaki (UK)
Is GDM predictable and preventable in the 1st trimester?

15.40 - 16.00

G. H. Visser (The Netherlands)
Diabetes and Pregnancy: bigger babies despite better control

16.00 - 16.20

U. Simeoni (Switzerland)
The newborn infant: which mother is it better to be born to?
Diabetic, obese, hypertensive, preterm?

16.20 - 16.30

Discussion

15.00 - 16.30

AUDITORIUM 2
SEMI-PLENARY 2:
DPL-NEO1) LONG-TERM OUTCOMES OF HIGH-RISK INFANTS

Chairpersons: E. Özek (Turkey); Linda de Vries (The Netherlands)

15.00 - 15.25

S. Johnson (USA)
Behavioural outcomes and psychiatric disorders following extremely preterm birth: Evidence from the EPICure Studies

15.25 - 15.50

L. de Vries (The Netherlands)
What are the long term outcomes of the mildly asphyxiated infants?

15.50 - 16.15

L. Helström-Westas (Sweden)
Long-term outcomes of extremely preterm infants in Sweden: Express study

16.15 - 16.30

Discussion

16.30 - 17.00

COFFEE BREAK AND POSTER VIEWING
TOPIC:
PREGNANCY/GENERAL

17.00 - 17.30

AUDITORIUM 1 + 2
MATERNITY PRIZE

E. Saling (Germany)
Maternity Prize

17.30 - 18.25

5 PARALLEL ROOMS - ORAL PRESENTATION SESSIONS

17.30 - 18.25

AUDITORIUM 2
ORAL COMMUNICATION TH2.A
- CESAREAN SECTION

Chairpersons: D. Gavilanes (The Netherland); D. Haumont (Belgium);

MATERNAL AND NEONATAL OUTCOMES OF THE GENTLE CAESAREAN DELIVERY: A CLINICAL REPORT OF ONE AND A HALF YEARS’ EXPERIENCE IN A DUTCH HOSPITAL
V. Wolters; K. Boers

LOW VERSUS NORMAL FIRST-TRIMESTER MATERNAL PAPP-A LEVELS AND PREGNANCY OUTCOME
M.Kaijomaa; L. Rahkonen; V-M. Ulander; E. Hämäläinen; H. Alfthan; H. Markkanen; S. Heinonen; V.Stefanovic

ADHERENCE TO GUIDELINE BASED QUALITY INDICATORS FOR CAESAREAN SECTIONS IN SOUTH AUSTRALIA
S.C.J. van Alphen; N.F.M. Anthonissen; G. Matthews; S. Kuah; G.A. Dekker; S. Kane; S.Melman; H.C.J. Scheepers; M. Woiski; R.P.M.G. Hermens; B.W. Mol

PATIENT DECISION AID WITH INDIVIDUAL RISK ESTIMATION: AN EFFECTIVE TOOL IN CHOOSING THE MODE OF DELIVERY AFTER CESAREAN SECTION
E.Vankan; E. Schoorel; S. van Kuijk; B. Mol;J. Nijhuis; R. Aardenburg; F. Delemarre; C. Dirksen; I. van Dooren; S. Kuppens; A. Kwee; J. Langenveld; L. Smits; R. Hermens; H. Scheepers

NICHE RATIO AFTER SINGLE- OR DOUBLE-LAYER INTERRUPTED CLOSURE: A PROSPECTIVE ASSESSMENT OF PRIMARY CESAREAN HYSTEROTOMY SCAR USING SALINE CONTRAST SONOHYSTEROGRAPHY
S. Kataoka; K. Tanaka; T. Fujii; K. Iwaki; Y. Iwaki; F.Tanuma

17.30 - 18.25

0.4 BRUSSELS
ORAL COMMUNICATION TH2.B
- PRETERM BIRTH

Chairpersons: Scheepers (the Netherlands); K. Bilardo (The Netherlands)

COMPARISON OF PARTOSURE (PAMG-1) AND ACTIM PARTUS (PHLGFBP-1) FOR THE PREDICTION OF PRETERM DELIVERY IN PATIENTS  WITH PRETERM LABOR AND A SHORT CERVIX
M. Hadzi Lega; L. Hellmeyer; H. Hanns; M. Josefine; A. Poposka; A. Daneva Markova

AN INFLUENCE OF INTERLEUKIN-6 ON THE RISK OF PRETERM LABOUR IN PATIENTS WITH EXCESSIVE BMI
P. Ossowski; M. Radoń – Pokracka; J. Spaczyńska; A. Gadamer; M. Nowak;  H. Huras

PHOSPHORYLATED INSULIN - LIKE GROWTH FACTOR BINDING PROTEIN - 1 IN THE PREDICTION OF PRETERM DELIVERY IN PATIENTS WITH PRETERM LABOR
N. Nikolova; T. Nikolova; S. Jovchevski; M. Micevska

CONTINUOUS AMNIOINFUSION VIA A SUBCUTANEOUSLY IMPLANTED PORT SYSTEM WITH PPROM AND OLIGO-/ANHYDRAMNIOS <28+0 WEEKS OF GESTATION: AN INTERNATIONAL PROSPECTIVE RANDOMIZED TRIAL
Y. Naberezhnev; S. Göbel; G. Seliger; M. Tchirikov

A COMPARISON BETWEEN THE PHOSPHORYLATED INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1 AND THE CERVICAL LENGTH IN PREDICTION OF SAMPLING TO DELIVERY TIME IN PATIENTS WITH PRETERM LABOR
N. Nikolova; T. Nikolova; S. Jovchevski; M. Micevska; S. Nikolovski

 

 

17.30 - 18.25

0.5 PARIS
ORAL COMMUNICATION TH2.C
- TWINS 1

Chairpersons: E. Lopriore (the Netherlands); G. C. Smith (UK)

MONOCHORIONIC TWINS AND SINGLE INTRAUTERINE DEMISE: NEUROLOGICAL OUTCOME
M. De la Calle; I. Duyos; E. Antolín, A. Fernández; JL. Bartha

TRIAL OF LABOR IN GROWTH ESTIMATED DISCORDANT TWINS
K.E.A. Hack; C.S. Pietersma; R. Rijpma; R.J. Derks

ADVERSE OBSTETRIC OUTCOMES WITH ENDOMETRIOSIS: META-ANALYSES
Y.S. Kim

IS THE RISK OF INRAHEPATIC CHOLESTASIS OF PREGNANCY RELATED TO BODY MASS INDEX IN WOMEN PREGNANT WITH TWIN ?
K. Kosinska-Kaczynska; I. Szymusik

OBSTETRICAL OUTCOME OF SPONTANEOUS TWINS PREGNANCY VERSUS IVF TWINS PREGNANCY
C. Larrañaga; S. García; M. Urtasun; M. Donazar; A. Safont;  N. Abian; B. Pérez; J. Barrenetxea

17.30 - 18.25

0.2/0.3 BERLIN/COPENHAGEN
ORAL COMMUNICATION TH2.D
- OUTCOME

Chairpersons: C. Lees (UK)

MATERNAL INFLAMMATORY BOWEL DISEASE DURING PREGNANCY IS NOT A RISK FACTOR FOR LONG-TERM MORBIDITY OF THE OFFSPRING
A. Freud; O. Beharier; A. Walfisch; R. Sergienko; D. Landau; E. Sheiner

THE ASSOCIATION OF NEONATAL MORBIDITY AND LONG TERM NEUROLOGICAL OUTCOME IN INFANTS WHO WERE GROWTH RESTRICTED AND PRETERM AT BIRTH
A.G. van Wassenaer-Leemhuis; N. Marlow; C. Lees; H. Wolf for the TRUFFLE research group

GROWTH FROM BIRTH TO AGE 12.5 IN CHILDREN BORN GROWTH RESTRICTED
F. Beukers; J. Rotteveel; M. van Weissenbruch; J.W. Ganzevoort; J.B. van Goudoever; A.G. van Wassenaer-Leemhuis

USE OF MAGNESIUM SULFATE IN SEVERE PERINATAL ASPHYXIA AND SHORT-TERM NEUROLOGIC OUTCOMES
G. Mullalli-Bime; G. Kuli-Lito; E. Tushe

FETAL GENDER AS A PREDICTOR FOR ADVERSE PERINATAL OUTCOMES
Y. Baumfeld; D. Yohay; T. Zilberstein; B. Aricha-Tamir; S. Yaniv Salem; B. Hamou; D. Elharar; I. Idan; Z. Yoahy; E. Sheiner

17.30 - 18.25

0.11 PRESS ROOM
ORAL COMMUNICATION TH2.E
- NEONATAL LUNG

Chairpersons: Villamor (the Netherlands)

PULMONARY INVOLVEMENT IN NEONATAL LUPUS: A CHALLENGING DIAGNOSIS
F. Flor-de-Lima; S. Pereira; I. Sanmarful; H. Soares; A. Vilan; M. Rodrigues; C. Moura; I. Brito; H. Guimarães

ONE YEAR PULMONARY OUTCOMES IN THE TRIAL OF LATE SURFACTANT (TOLSURF)
P. Ballard; R. Keller; E. Rogers; E. Eichenwald; A. Hibbs; D. Black; K. Wai; J. Asselin; R. Ballard for the TOLSURF study investigators

HEART RATE CHARACTERISTICS INDEX AND EXTUBATION OUTCOME IN NEONATES: A RETROSPECTIVE COHORT STUDY
S. Banerjee; N. Goel; M. Chakraborty; W.J. Watkins; S.Z. Ansari

PULSE OXIMETER SATURATION TARGET LIMITS FOR PRETERM INFANTS: A SURVEY AMONG EUROPEAN NICUS
M. J. Huizing; E. Villamor-Martinez; M. Vento; E. Villamor

THE FEASIBILITY OF ULTRASOUND DIAGNOSTICS IN CONFIRMATION OF ENDOTRACHEAL TUBE POSITION IN NEONATES
A. Erokhina; I. Koltunov; M. Degtyareva; A. Mazaev; A. Gorbunov; K. Chusov; A. Demina

 

DAY 3 - Friday June 17th

08.00 - 08.55

5 PARALLEL ROOMS - ORAL PRESENTATION SESSIONS

08.00 - 08.55

AUDITORIUM 2
ORAL COMMUNICATION FR1.A
- DOCTORS AND MIDWIVES: CARE OR CURE

Chairpersons: J. Derks (The Netherlands); A. Kalugina (Russia)

THE EFFECT OF ATTENDING A PRENATAL CHILDBIRTH PREPARATION COURSE ON LABOR DURATION AND OUTCOMES
D. Yohay; AY. Weintraub; D. Elharar; B. Aricha-Tamir; R. Cohen; Z. Kalatian-Meloul

WHY HOME OR HOSPITAL BIRTH? A QUALITATIVE STUDY EXPLORING WOMEN'S MOTIVES AND PREFERENCES ABOUT PLACE OF BIRTH IN THE NETHERLANDS
T. van Haaren - ten Haken; M. Hendrix; M. Nieuwenhuijze; J. Nijhuis; R. de Vries

DOES A POP-TEAM CONTRIBUTE TO THE PREVENTION OF CHILD ABUSE
I. van Wanrooij; J.H.A.M. Tuerlings; K.de Boer; A. Plaisier;  J.de Waal; J.C. Smal

WHY WOMEN WANT OTHER OR NO DELIVERY CARE (WONDER STUDY)
M. Hollander; L. Holten; J. van Dillen; E. de Miranda

ASSESMENT OF ATTITUDES AND SATISFACTION AMONG WOMEN WHO UNDERGONE CESAREAN SECTION WITHOUT MEDICAL INDICATION
T. Eshkoli; A. Bashiri; A.Y. Weintraub;  B. Aricha-Tamir; Z. Yohay; D. Yohay

08.00 - 08.55

0.4 BRUSSELS
ORAL COMMUNICATION FR1.B
- FETAL ULTRASOUND

Chairpersons: ; V. Carnielli (Italy); F. Van Bel (The Netherlands)

IMPACT OF PRENATAL EVALUATION OF CONGENITAL MALFORMATIONS IN FETUS ON POSTOPERATIVE MORTALITY
I.Y. Gordienko; O.M. Tarapurova; G.O.Grebinichenko; O.K. Slepov; A.V. Velichko

ULTRASOUND EVALUATION OF FOETAL SPINE POSITION AND SUCCESS RATE OF THE MANUAL ROTATION OF FOETUS IN OCCIPUT POSTERIOR POSITION: A PILOT STUDY
L. Attamante; B. Masturzo; A. Farina; A. Piazzese; T. Todros

ACCURACY OF MID-TRIMESTER TRANSCEREBELLAR DIAMETER MEASUREMENTS FOR PREGNANCY DATING
A. Gokce; E. Kalafat; T. Yuce; O. Ulusoy; K. Baydemir; F. Soylemez

FETAL CARDIAC TUMOR
A. Safont; M. Donázar; B. Gastón; J. Barrenetxea; M. Urtasun; S. Garcia; C. Larrañaga; N. Abián

FETAL INTRAABDOMINAL UMBILICAL VEIN VARIX : ANTENATAL DIAGNOSIS AND MANAGEMENT
M.A. Ozek; P. Calis; M. Bayram; D. Karcaaltincaba

08.00 - 08.55

0.5 PARIS
ORAL COMMUNICATION FR1.C
- PREECLAMPSIA

Chairpersons: ; O. Koren (Israel); Oei (the Netherlands)

MITOCHONDRIAL DNA METHYLATION IN FETAL CORD BLOOD OF IUGR AND PREECLAMPTIC PREGNANCIES
C. Novielli; C. Mandò; S. Tabano; N. Carlessi; P. Antonazzo; G.M. Anelli; M. Miozzo; I. Cetin

RISK FACTORS FOR CARDIOVASCULAR DISEASE 11-14 YEARS AFTER SEVERE PREECLAMPSIA
E. Andolf; C. Salminen-Friesendahl; M. Thorsell; C. Iacobaeus

HYPERTENSIVE PREGNANT: RELATIONSHIP BETWEEN DRUG THERAPY AND TENSION CONTROL
M. Boia; A. Cadete; S. Vidal; A. Correia; C. Rainho; R. Ferreira ; L. Sutil; M. Bastos

WHICH STRATEGY PERFORMS BETTER FOR THE PREDICTION OF LATE PE?
E. Meler; G. Albaiges; I. Rodriguez

A RANDOMIZED CONTROLLED TRIAL OF LOADING DOSE ONLY VERSUS STANDARD DOSE MAGNESIUM SULFATE SEIZURE PROPHYLAXIS IN SEVERE PRE-ECLAMPTIC WOMEN
S.P. Rimal; R. Rijal; R. Bhatt

08.00 - 08.55

0.2/0.3 BERLIN/COPENHAGEN
ORAL COMMUNICATION FR1.D
- THE PRETERM INFANT 2

Chairpersons: A. Kribs (Germany)

HIGH LOADING DOSE OF CAFFEINE CITRATE IN PRETERM INFANTS AND THE EFFECTS ON CRANIAL ULTRASOUND FINDINGS AND NEUROLOGICAL OUTCOMES
P.H. Gray; B. Firman

THE USE OF SERUM CNS DAMAGES MARKERS FOR ASSESSING THE PERINATAL OUTCOMES OF PRETERM BIRTH
I. Ignatko; A. Strizhakov; N. Popova

PERINATAL RİSK FACTORS AND MODE OF DELIVERY ASSOCIATED WITH NEONATAL MORTALITY AMONG VERY LOW BIRTH WEIGHT INFANTS BEFORE 28 WEEKS OF GESTATION
F. Soylemez; S. E. Cetinkaya; S. Sahin;A. Koc; E. Okulu; H. Akduman; B. Atasay; S. Arsan

RELATIONSHIP BETWEEN PRETERM BIRTH, NEONATAL OUTCOMES AND LOW MATERNAL HEMOGLOBIN LEVEL
M. Radon-Pokracka; H. Huras; J. Spaczynska; M. Nowak; P. Ossowski; P. Janas

IMPACT OF SOCIOECONOMIC ENVIRONMENT IN COGNITIVE DEVELOPMENT OF FIVE YEARS OLD CHILDREN BORN PRETERM
S. Dirani; V. Datin-Dorriere; B. Guillois; P. Thibon; G. Launoy; L. Launay

08.00 - 08.55

0.11 PRESS ROOM
ORAL COMMUNICATION FR1.E
- QUALITY AND CARE: NEONATAL

Chairpersons: V. Fanos (Italy)

MATERNAL MILK SUPPLEMENTATION AS PART OF LACTATION SUPPORT INTERVENTION IMPROVES BREASTFEEDING PERFORMANCE, BIRTH AND GROWTH OUTCOMES
D. Huynh; N. T. Tran; L. T. Nguyen; Y. Berde; Y. L. Low

A SITUATIONAL SIMULATION TRAINING SCHEME FOR MEDICAL AND NURSING STAFF IN NEONATAL UNIT
M. Ali; D. Boyd

VISIT THE CHILD IN THE INTENSIVE CARE UNIT IN A PUBLIC HOSPITAL: DEVELOPMENT OF PROTOCOL
E. Kahhale; S .Taba

IMPACT OF RAPID ENTERAL FEEDING IN VERY LOW BIRTH WEIGHT INFANTS: SAINT OR SINNER ?
F. Belling-Dierks; K. Glaser; J. Wirbelauer; V. Rücker; E. Frieauff

PREVENTION AND TREATMENT OF FETAL CYTOMEGALOVIRUS INFECTION WITH CMV-HYPERIMMUNE GLOBULIN: A MULTICENTRE STUDY IN MADRID (GECITMA GROUP)
M. De la Calle; D. Blázquez-Gamero; A. Galindo Izquierdo; F. Baquero-Artigao: N. Izquierdo Méndez; M. Soriano-Ramos; P. Rojo Conejo; MI. González-Tomé; T. Rosal; A. García-Burguillo; N. Pérez Pérez; V. Sánchez

09.00-10.30

AUDITORIUM 1 + 2
PLENARY:
PLM7) PERINATAL PROGRAMMING

Chairpersons: A. Athanasiadis (Greece); E. Herting (Germany)

09.00 - 09.30

C. Redman (UK)
Placentally mediated disease: antecedent risks, pathogenesis and consequences

09.30 - 10.00

E. Gratacos (Spain)
Fetal programming: impact of IUGR

10.00 - 10.30

M. Hanson (UK)
Periconceptional programming

10.30 - 11.00

COFFEE BREAK AND POSTER VIEWING
TOPICS:
PREGNANCY/THE MOTHER and THE NEONATE

11.00 - 12.30

AUDITORIUM 1
PARALLEL 1: SEESPM SESSION

"CEASAREAN SECTION: SHOULD WE DO SOMETHING DIFFERENT"

Chairpersons: R. Matijevic (Croatia); O. Kontic-Vucinic (Serbia); A. Athanasiadis(Greece)

PART 1 "30 YEARS TRENDS OF CAESAREAN SECTION"

11.00 - 11.10

S. Crnogorac (Montenegro)

11.10 - 11.20

A. Antsaklis (Greece)

11.20 - 11.30

R. Matijevic (Croatia)

11.30 - 11.40

T. Premru (Slovenia)

 

PART 2 PANNEL: "SEESPM: Using a Classification System to Compare, Interpret, and Improve Perinatal Data"

11.40 - 12.10

S. Premru (Slovenia)
M. Lucovnik (Slovenia)
R. Matijevic (Croatia)
M. Hadzi Lega (Macedonia)
F. Stamatian (Romania)
S. Crnogorac (Montenegro)
O. Kontic (Serbia)


PART 3

12.10 - 12.20

S. Beksac (Turkey)
A Computerized decision making system for the route of delivery; vaginal versus cesarean section delivery

12.20 - 12.30

N. Radunovic (Serbia)
Possible association between Cesarean Section and autism spectrum disorders

11.00 - 12.30

AUDITORIUM 2
PARALLEL 2:
FRI PAR-M4) FETAL THERAPY 

Chairpersons: J. Deprest (Belgium); A. Mikhailov (Russia)

11.00 - 11.20

K. Hecher (Germany)
Clinical aspects of TTTS

11.20 - 11.40

E. Lopriore (Italy)
Long term outcome after fetal theraphy in twins

11.40 - 12.00

J. Deprest (Belgium)
FETO procedure in CDH

12.00 - 12.20

M. Meuli (Switzerland)
Open fetal surgery

12.20 - 12.30

Discussion

11.00 - 12.30

0.4/0.5 BRUSSELS/PARIS
PARALLEL 3: FRI PAR-M5) OPTIMAL TIMING OF UMBILICAL CORD CLAMPING

Chairpersons: H. Rabe (UK); T.Bui (Sweden)

11.00 - 11.15

Maternal aspects on umbilical cord clamping

11.15 - 11.30

O. Andersson (Sweden)
Short and long-term effects related to timing of cord clamping in term infants

11.30 - 11.45

H. Rabe (UK)
Effects of delayed cord clamping in preterm infants

11.45 - 12.00

The hemodynamics of umbilical cord clamping

12.00 - 12.15

Rescuing the neonatal brain from hypoxic injury with autologous cord blood

12.15 - 12.30

Discussion

11.00 - 12.30

0.2/0.3 BERLIN/COPENHAGEN
PARALLEL 4:
FRI PAR-OB2) GDM - TOWARDS A EUROPEAN CONSENSUS

Chairpersons: M. Hod (Israel); M. Wielgos (Poland) 

11.00 - 11.20

H. Divakar  (India) 
Health system and societal barriers in improving diabetes related maternal health

11.20 - 11.40

T. Mahmood (UK) EBCOG President
The EBCOG approach

11.40 - 12.00

M. Maresh (UK)
The NICE approach

12.00 - 12.20

M. Hod (Israel)
Towards a Global Consensus; the FIGO Initiative on Hyperglycemia in Pregnancy (HIP)

12.20 - 12.30

Discussion

 

11.00 - 12.30

0.11 PRESS ROOM
PARALLEL 5:
FRI PAR-NEO4) BRONCHOPULMONARY DYSPLASIA

Chairpersons: L. Zimmermann (The Netherlands), B. W. Kramer (The Netherlands)

11.00 - 11.20

C. P. Speer (Germany)
Pathogenesis of BPD

11.20 - 11.40

E. Baraldi (Italy)
BPD and long-term lung function

11.40 - 12.00

B. W. Kramer (The Netherlands)
Stem cells for treatment of BPD

12.00 - 12.20

E. Shepherd (USA)
Clinical management of BPD

12.20 - 12.30

Discussion

 

12.30 - 13.30

EXHIBITION & POSTER VIEWING

 

12.30 - 13.30

0.2/0.3 BERLIN/COPENHAGEN
EAPM GENERAL ASSEMBLY

 

13.30 - 14.30

0.4/0.5 BRUSSELS/PARIS
SPONSORED SYMPOSIUM
*see sponsored sessions

 

13.30 - 14.30

AUDITORIUM 1 + 2
PLENARY:
PLM4+5) THE OMICS IN PERINATAL MEDICINE

Chairpersons: G. Donzelli (Italy); G. Sukhikh (Russia)

13.30 - 13.50

V. Fanos (Italy)
Metabolomics in perinatal medicine

13.50 - 14.10

T. Bui (Sweden)
Genomics in perinatal medicine

14.10 - 14.30

A. Athanasiadis (Greece)
Reflection of maternal nutrition in the 2nd trimester amniotic fluid metabolic profile

14.30 - 16.00

AUDITORIUM 1
PARALLEL 1:
36) PERINATAL STROKE

Chairpersons: E. Saliba (France); P.Gressens (France)

14.30 - 15.00

E. Saliba (France)
Genetic, obstetric and neonatal charact. of infants developing art. ischaemic stroke

15.00 - 15.30

M. Benders (The Netherlands)
Pathogenesis, diagnostics and therapeutic options

15.30 - 16.00

L. De Vries (The Netherlands)
Sinovenous thrombosis: Pathogenesis, diagnostics and therapeutic options

14.30 - 16.00

AUDITORIUM 2
PARALLEL 2:
PAR-OB5) HOME DELIVERY

Chairpersons: A. Kwee (The Netherlands) ; F.A. Chervenak(USA)

14.30 - 15.00

J. Nijhuis (The Netherlands)
Home deliveries in 2016

15.00 - 15.30

A. De Jonge (The Netherlands)
Home delivery- is it still safe?

15.30 - 16.00

F. A. Chervenak (USA)
Planned home birth: the professional responsibility response

14.30 - 16.00

0.4/0.5 BRUSSELS/PARIS
PARALLEL 3:
FRI PAR-M8) PREGNANCY 'ENGINEERING'

Chairpersons: F. Figueras (Spain) ; F. Vialard (France)

14.30 - 14.50

U-B Wennerholm (Sweden)
Maternal and perinatal outcomes of oocyte donation

14.50 - 15.10

F. Vialard (France)
ART and the long term consequences on the offspring

15.10 - 15.30

G. De Wert (The Netherlands)
Ethical aspects of preimplantation genetic diagnosis and screening

15.30 - 15.50

A. Kalugina (Russia) 
Obstetric and perinatal outcomes after Transplantation of cryopreserved ovarian tissue in cancer survivors

15.50 - 16.00

Discussion

14.30 - 16.00

0.2/0.3 BERLIN/COPENHAGEN
PARALLEL 4:
FRI PAR-OB4) CAN WE PREVENT INTRAUTERINE FETAL DEATH?

Chairperson: G. H. A. Visser (The Netherlands) ; A. Mikhailov (Russia)

14.30 - 14.45

G. H. A. Visser
What is the optimal fetal growth

14.45 - 15.00

A. Khalil (UK)
How to identify the 3rd trimester fetus at risk

15.00 - 15.15

L. Poon (UK)
How to identify the 3rd trimester fetus at risk

15.15 - 15.30

F. Figueras (Spain)
How to identify the 3rd trimester fetus at risk

15.30 - 15.45

G. C. Smith (UK)
Predicting antepartum stillbirth

15.45 - 16.00

Discussion

14.30 - 16.00

0.11 PRESS ROOM
PARALLEL 5:
FRI PAR-NEO3) DEVELOPMENTAL CARE

Chairpersons: S. Mader (Germany); M. Cuttini (Italy)

14.30 - 14.48

S. Mader (Germany)
Family perspectives on neonatal intensive care

14.48 - 15.06

D. Haumont (Belgium)
Family centred NICU care

15.06 - 15.24

S. Ludington-Hoe (UK)
Skin-to-skin (KMC) care

15.24 - 15.42

N. Conneman (The Netherlands)
The essence of NIDCAP

15.42 - 16.00

G. P. Donzelli (Italy)
At the confluence of narrative medicine and precision medicine: what lies downstream?

16.00 - 16.30

COFFEE BREAK AND POSTER VIEWING
TOPICS:
PERINATAL INFECTION and THE FETUS       

16.30 - 17.30

AUDITORIUM 1
SEMI-PLENARY 1:
DPL-OB2) FIRST TRIMESTER RISK ASSESSMENT

Chairpersons: K. Devriendt (Belgium) ; A.Khalil (UK)

16.30 - 16.45

L. Poon(UK)
The place of NT in modern perinatal medicine

16.45 - 17.00

G. Makrydimas (Greece)
Increased NT implications for the fetus

17.00 - 17.15

W. Gyselaers (Belgium)
Economic aspects of NIPT as a national health care service

17.15 - 17.30

K. Devriendt (Belgium)
Clinical results of NIPT: possibilities and limitations

16.30 - 17.30

AUDITORIUM 2
SEMI-PLENARY 2:
PLM3) PREVENTION AND MANAGEMENT OF PRETERM BIRTH

Chairpersons: M. Hod (Israel)

16.30 - 16.50

V. Berghella  (USA)
Short cervical length: so much data, may choices

16.50 - 17.10

A. Shennan (UK)
Optimum

17.10 - 17.30

G. C. Di Renzo (Italy)
European Guidelines on Preterm Labour

17.30 - 18.25

5 PARALLEL ROOMS - ORAL PRESENTATION SESSIONS

17.30 - 18.25

AUDITORIUM 2
ORAL COMMUNICATION FR2.A
- FETAL GROWTH RESTRICTION

Chairpersons: Van de Berg (the Netherlands); K. Hecher (Germany)

ASSOCIATION OF MID-TRIMESTER DOPPLER PARAMETERS WITH ABDOMINAL CIRCUMFERENCE PERCENTILE IN LOW-RISK PREGNANT WOMEN
A. Gokce; T. Yuce; E. Kalafat; A. Koc

ANTITHROMBOTIC MEDICATION IN PREGNANT WOMEN WITH PREVIOUS INTRAUTERINE GROWTH RESTRICTION
L. Vakrilova; K. Neykova; V. Dimitrova; R. Dimitrov

VALIDATION OF A PREDICTIVE RISK MODEL FOR ADVERSE PERINATAL OUTCOME IN LATE-ONSET SMALL FOR GESTATIONAL AGE FETUSES
A. Vázquez-Sarandeses; E. Gómez-Montes; I. Herraiz; P.I. Gómez-Arriaga; M.S. Quezada; A. Galindo

EARLY MARKERS OF ENDOCRINO-METABOLIC DISEASE IN GROWTH RESTRICTED FETUSES
I. Alonso Larruscain; J.L. Ruibal Francisco; C. Notario Muñoz

PROTEOMIC TECHNOLOGIES IN PRENATAL DIAGNOSIS
V.A. Linde; T.N. Pogorelova; V.O. Gunko; I.I. Krukier; A.A. Nikashina; N.V. Palieva; V.V. Avrutskaya; Z.A. Elzhorukaeva

17.30 - 18.25

0.4 BRUSSELS
ORAL COMMUNICATION FR2.B
- INFECTION & SURROUNDINGS 2

Chairperson: G. Lista (Italy)

HISTOLOGICAL CHORIOAMNIONITIS: DOES IT PREVENT LATE-ONSET SEPSIS IN PRETERM INFANTS ?
M. van Doorn;  J. van der Voorn; M. van Weissenbruch;  D. Visser

ANTI-INFLAMMATORY EFFECTS OF BUDESONIDE IN HUMAN FETAL LUNG
P. Ballard; A. Barrette; J. Roberts; E. Egan

PATHOGEN TO KEEP IN MIND: UREAPLASMA SPECIES INDUCE PRO-INFLAMMATORY IMMUNE RESPONSES IN HUMAN NEONATAL AND ADULT MONOCYTES
K. Glaser; M. Fehrholz; B. Henrich; H. Claus; C. P. Speer

TIME TO POSITIVITY (TTP) OF NEONATAL BLOOD CULTURES: ANALYSIS OVER A DECADE FROM AN IRISH REGIONAL NEONATAL UNIT
R. Philip; D. Huggard; J. Powell; C. Kirkham;  N. O’Connell; L. Power

PREDICTIVE VALUE OF AMNIOTIC INTERLEUKIN - 6 FOR INTRAAMNIOTIC INFLAMMATION IN WOMEN WITH PPROM AND FOR EARLY- ONSET SEPSIS IN THEIR NEONATES
V. Korecko; A. Mockova; M. Kozerovsky; J. Dort; M. Kapoun

17.30 - 18.25

0.5 PARIS
ORAL COMMUNICATION FR2.C
- TWINS 2

Chairpersons: W. Gyselaers (Belgium); I. Blickstein (Israel)

THE USE OF CERVICAL PESSARY IN A SPANISH POPULATION OF TRIPLET PREGNANCIES
M. De la Calle; T. Illescas; M. Goya; S. Fernandez; S. Arevalo; E. Martin Boado; C. Rodo; E. Carrera; J.L. Bartha

PREMATURITY-RELATED BRAIN LESIONS AND PLACENTA CHARACTERISTICS IN SINGLETON AND TWIN VLBW INFANTS
M. Malova; D. Brignole; A. Parodi; E. Fulcheri; M. Severino; G. Morana; A. Rossi; L.A. Ramenghi

EVALUATION OF THE IMPLEMENTATION OF THE DUTCH NATIONAL GUIDELINE ON TWIN PREGNANCIES AND ITS EFFECTS ON PERINATAL OUTCOME OF MONOCHORIONIC TWIN PREGNANCIES
W.M. Post; K.E. Hack; J. Boon; I.M. Evers; A.P. Drogtrop; P.F. Boekkooi; G.C. Graziosi;  A.J.M. Huisjes; J.B. Derks

NECROTIZING ENTEROCOLITIS  IN TWIN PREGNANCIES: CAN WE FIND A PATHOPHYSIOLOGIC KEY IN PLACENTAL ABNORMALITIES ?
R.R. Aapkes; P.G.J. Nikkels; C. Koopman-Esseboom; K.E.A. Hack

THE NEONATAL OUTCOME IN TWIN GESTATIONS COMPLICATED WITH SELECTIVE OR NON-SELECTIVE INTRAUTERINE GROWTH RESTRICTION
K. Kosinska-Kaczynska; W. Ananicz; J. Maret; K. Szarla; I. Szymusik

17.30 - 18.25

0.2/0.3 BERLIN/COPENHAGEN
ORAL COMMUNICATION FR2.D
- CULTURE AND CHALLENGES

Chairperson: L. Hellström-Westas (Sweden)

BREAKING THE CULTURAL AND SOCIAL TABOOS ASSOCIATED WITH WOMEN SEXUALITY IN PAKISTAN
S. Sohail; A. Samuel

ADOLESCENT CONTRACEPTION BEFORE AND AFTER CHILDBIRTH—CHOICES AND CHALLENGES FOR THE FUTURE
A. Pinheiro; F.G. Surita; A.D. Annibale; R.C. Pacagnella; J.L. Pinto e Silva

IMPACT ON OBSTETRIC INDICATORS OF CENTRAL FETAL MONITORING WITH COMPUTER ANALYSIS OF CARDIOTOCOGRAPHIC SIGNALS AND REAL-TIME ALERTS
J. Pereira; A. Costa; C. Costa-Santos; D. Ayres-de-Campos; J. Bernardes

OBSTETRICAL AND PERINATAL OUTCOME OF OLDEST PREGNANT WOMEN
C. Larrañaga; S. García; M. Urtasun; M. Donazar; A. Safont; N. Abian; B. Pérez

OUTCOMES FROM BIRTH TO HOSPITAL DISCHARGE OF INFANTS WITH TRACHEO-OESPHAEGAL FISTULA /OESOPHAGEAL ATRESIA FROM A UK – BASED TERTIARY NEONATAL SURGICAL CENTRE OVER 8 YEARS
A. Kalugina, O. Bystrova, E. Lapina, A. Lisyanskaya, G. Manikhas

17.30 - 18.25

0.11 PRESS ROOM
ORAL COMMUNICATION FR2.E
- GENERAL OBSTETRICS 1

Chairpersons: T. Bui (Sweden)

CERVICAL BIOMARKERS AS PREDICTORS OF SUCCESSFUL LABOR INDUCTION BY FOLEY CATHETER
H. Kruit; O. Heikinheimo; T. Sorsa; J. Juhila; J. Paavonen; L. Rahkonen

PLATELETS IN FIRST TRIMESTER AS A PREDICTOR OF PERINATAL OUTCOME: A BASED POPULATION STUDY
G. Nozaleda Pastor;A. Garcia Carreras; S. Garcia-Tizon Larroca; S. Lizárraga Bonelli

OBSERVATIONAL STUDY OF MISOPROSTOL 200 µG VAGINAL DELIVERY SYSTEM (MISODEL®) IN DUTCH OBSTETRIC PRACTICE
J. Baalman; J. van Eyck; T. Hasaart; N. van Gemund; R. Pal; G. Muijsers; M. Verbeek; R. Olivier; J. Lenglet; H. Versendaal; H. Mous; H. Feitsma; D. Schippers; E Creutzberg

MINOR ALTERATIONS OF GLUCOSE METABOLISM: THE FLAT OGTT AND ITS EFFECTS ON FETAL GROWTH
M.P. Rambaldi; D. Paoli; L. Cecconi; S. Simeone; C. Serena; S. Ottanelli; G. Mello; F. Mecacci

FATTY ACID PROFILES AT ANTENATAL BOOKING ARE A PREDICTOR OF GESTATIONAL DIABETES MELLITUS
S. Samuelson; M.R. Johnson; M.A. Crawford; Y. Wang; E. Ogundipe

 

 

DAY 4 - Saturday June 18th

08.00 - 08.55

5 PARALLEL ROOMS - ORAL PRESENTATION SESSIONS

08.00 - 08.55

AUDITORIUM 2
ORAL COMMUNICATION SA1.A
- FIRST TRIMETER SCREENING AND PREVENTION STRATEGIES

Chairperson: F. Figueras (Spain)

DETECTION OF 15Q (PRADER WILLI/ANGELMAN) DELETION IN MATERNAL CELL-FREE FETAL DNA TEST; A CASE REPORT
O. Tosun; C. Batukan; O.Takmaz; C. Yakicier; Y.Alanay; E. Ozbasli

FIRST TRIMESTER BIOCHEMICAL SCREENING IN FEMALE KIDNEY AND LIVER GRAFT RECIPIENTS
N. Mazanowska; B. Pietrzak; P. Kosinski; M. Wielgos

ACCURACY AND REPRODUCIBILITY OF FETAL FRACTION MEASUREMENT USING QUANTITATION AT POLYMORPHIC LOCI WITH MICROARRAY
K. Fergus; M. Schmid; D. Miller; K. White; T. Musci; E. Wang

FETAL ANEUPLOIDY SCREENING RESULTS IN MATERNAL PLASMA SAMPLES REDRAWN DUE TO INSUFFICIENT FETAL CFDNA IN THE INITIAL SAMPLE
M. Schmid; T. Musc; K. Song; E. Wang; K. Fergus

HIPOTHYROIDISM SCREENING DURING PREGNANCY
M. Castillo Lara; E. Soto Pazos; C. González Macías; JJ.
Fernández Alba; LJ. Moreno Corral y  R. Torrejón Cardoso

08.00 - 08.55

0.4 BRUSSELS
ORAL COMMUNICATION SA1.B
- INTRAPARTUM SURVEILLANCE 2

Chairpersons: I. Cetin (Italy); G. Makrydimas (Greece)

DOES SUBACUTE HYPOXIC PATTERN ON THE CTG TRACE DURING ACTIVE SECOND STAGE OF LABOUR RESULT IN POOR NEONATAL OUTCOMES ?
E.Chandraharan; A. Albertson; V. Lowe; A. Archer; I. Amer-Wåhlin

ELECTRONIC FETAL MONITORING DURING LABOR:  COMPARISON OF ABDOMINAL FETAL ELECTROCARDIOGRAPHY AND DOPPLER CARDIOTOCOGRAPHY
E.Grossi; P.Antonazzo; V.M. Savasi; I.Cetin

THE FIGO 3-TIER SYSTEM OF ASSESSING FETAL HEART RATE TRACINGS IS SUPERIOR TO THE NICHD 3-TIER SYSTEM IN DETECTING NEONATAL ACIDEMIA
S. Marti Gamboa; O. Redrado Gimenez; J. Ruiz Sada; J. 
Pascual Mancho; M.  Rodrigo Rodriguez; L. Rodriguez Lazaro; M. Lapresta Moros; S. Castan Mateo

SIGNIFICANCE OF THE FIRST HOUR OF THE FETAL HEART RATE MONITORING: NONREACTIVE VS REACTIVE INITIAL TRACE
A. Georgieva; A. Ugwumadu; A. Papageorghiou; C.W.G. Redman

REMIFENTANIL ELICITS A SINUSOIDAL HEART RATE PATTERN IN THE HUMAN FETUS
D. Boterenbrood; M.M. Wassen; G.H.A. Visser; J.G. Nijhuis

08.00 - 08.55

0.5. PARIS
ORAL COMMUNICATION SA1.C
- GENERAL OBSTETRICS 2

Chairpersons: J. Derks (The Netherlands)

BIRTH AT 37 WEEKS GESTATION AND ASSOCIATED PERINATAL RISKS VERSUS TERM DELIVERY - CASE-CONTROL STUDY
M.L. Ognean; O. Boantă; C. Zgârcea; R. Dumitra; S.A.Kovacs; R. Chicea

EXPECTED FINANCIAL AND HEALTH IMPACT OF ADVISING PREGNANT WOMEN TO USE CALCIUM SUPPLEMENTS: A DECISION ANALYSIS
L.J.E. Meertens; H.C.J. Scheepers; J.P.M.M. Willemse; M.E.A. Spaanderman; L.J.M. Smits

OXIDATIVE STRESS: THEIR ROLE IN PREGNANCY AND MISCARRIAGE
Z. Grujic; I. Grujic; M. Bogavac; A. Nikolic; M. Milosevic Tosic

POLYHYDRAMNIOS IN PREGNANT WOMEN UNDERGOING LONG-TERM HEMODIALYSIS:   A TREATABLE PATHOLOGY, A HEMODIALYSIS DOSE ADEQUACY TOOL AND AN OUTCOME PREDICTOR
S. Kahhale; C. Luders; I. Noronha; S.M. Titan; R. Francisco;  M. Zugaib

FETAL SPEECH MOVEMENTS IN RESPONSE TO INTRAVAGINAL EMISSION OF MUSIC ARE DUE TO AUDITION, NOT TO VIBRATION
A. Garcia-Faura; V. Moens; E. Valladares; A. Gràcia; M. Lopez-Teijon

08.00 - 08.55

0.2/0.3 BERLIN/COPENHAGEN
ORAL COMMUNICATION SA1.D
- NEONATAL

Chairpersons: O. Andersson (Sweden); D. Gavilanes (the Netherlands)

NEOCLOT-STUDY: NEONATAL CENTRAL-VENOUS LINE OBSERVATIONAL STUDY ON THROMBOSIS
J.J. Sol; M. van de Loo; M. Boerma; C.H. van Ommen

THE PREDICTIVE VALUE OF AMNIOTIC FLUID PH AND ELECTROLYTES ON NEONATAL RESPIRATORY DISORDERS
M. Cetinkaya; S.Y. Semerci; B. Yucel; I.M. Erbas; O.S. Gunkaya; M. Talmac; A. Babayigit; B. Cebeci; G. Buyukkale

A MICROSCOPIC EVIDENCE FOR THE THROMBOGENICITY OF UMBILICAL CATHETERS
A. Sobczak; P. Kruczek; M. Homa; P. Kwinta

PROBIOTIC SUPPLEMENTATION AND RETINOPATHY OF PREMATURITY, BRONCHOPULMONARY DYSPLASIA AND PERIVENTRICULAR LEUKOMALACIA IN PRETERM INFANTS: A META-ANALYSIS
E. Villamor; E. Villamor-Martínez;  L. Filippi; G. Cavallaro; F. Mosca; P.L. J. Degraeuwe

THE BELGIAN PRENATAL MICROARRAY (BEMAPRE) CONSORTIUM: SHARING PRENATAL GENOMIC ARRAY DATA IN A NATIONAL DATABASE
J. Muys; Y. Jacquemyn; K. Janssens; BEMAPRE consortium; B. Blaumeiser

08.00 - 08.55

0.11 PRESS ROOM
ORAL COMMUNICATION SA1.E
- QUALITY AND CARE

Chairpersons: N. Conneman (the Netherlands)

VALIDATION OF NEW PROTOCOLS BY IN SITU SIMULATION (RED CODE)
L. Almeida; J. Miñano; S. Ferrero; J. Parra; C. Cardona; M.D. Gómez Roig

THE ADHERENCE TO THE POSTPARTUM HAEMORRHAGE GUIDELINES IN SOUTH AUSTRALIA, A RETROSPECTIVE STUDY
N. Anthonissen; S. van Alphen; G. Matthews; S. Kuah; S. Kane; G Dekker; R Hermens; M Woiski; B Mol

PREECLAMPSIA AND RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA IN VERY PRETERM NEONATES
F. A. Wilmink; J. Reijnierse; I. Reiss; E.A.P. Steegers; R. De Jonge

ASSESSMENT OF THE ACTUAL CARE ON POSTPARTUM HEMORRHAGE USING VIDEO IMAGES OF THE THIRD STAGE
H. Liesbeth; S. de Visser; M. Woiski; H. van Vugt; H. Scheepers; R. Hermens and the Fluxim study group

EXPERIENCE IN THE USE OF CARBETOCIN FOR PREVENTION OF MAJOR BLEEDING IN PRE-ECLAMPSIA
I. Bushtyreva; N. Kuznetsova; M. Umanskiy; V. Barinova; V. Chernavsky; G. Ilyasova; E. Fedorchenko

09.00 - 09.30

AUDITORIUM 1 +2
PLENARY:
CCHD Screening

Chairpersons: E. Villamor (the Netherlands); T. Orlikowski (Germany)

09.00 - 09.30

A. Ewer
CCHD Screening

09.30 - 10.30

AUDITORIUM 1
PARALLEL 1:
6) MATERNAL DISEASE IN PREGNANCY AND EFFECTS IN THE NEWBORN

Chairpersons: M. Spaanderman (The Netherlands); E. Saliba (France)

09.30 - 09.50

E. Özek (Turkey) 
Thyroid function in pregnancy and neonatal outcomes

09.50 - 10.10

I. Sundström Poromaa (Sweden)
Are SSRI safe in pregnancy? Antenatal depression and placental gene expression

10.10 - 10.30

M. Wielgos (Poland) 
Pregnancy after kidney and liver transplantation: effects on graft, mother and neonate

09.30 - 10.30

AUDITORIUM 2
PARALLEL 2:
SAT PAR-M9) PERINATAL ASPHYXIA

Chairpersons: A. Kwee (The Netherlands); L. de Vries (the Netherlands)

09.30 - 09.50

C. Heijnen (The Netherlands)
Mesenchymal stem cells for hypoxic-ischaemic brain injury stem cells

09.50 - 10.10

J. Derks (The Netherlands)
Antenatal neuroprotection - an overview

10.10 - 10.30

M. Thoresen (UK)
Hypothermia and beyond

09.30 - 10.30

0.4/0.5 BRUSSELS/PARIS
PARALLEL 3:
SAT PAR-M10) PERINATAL MORTALITY

Chairpersons: J.G. Nijhuis (The Netherlands); E. Herting (Germany)

09.30 - 09.45

W. Gyselaers (Belgium)
Perinatal audit: should we focus on "mortalities" or "morbidities"?

09.45 - 10.00

J. Zeitlin (France)
EuroPeristat: epidemiology and European comparisons

10.00 - 10.15

A. Mikhailov (Russia) 
Pregnancy care for prenatally diagnosed lethal fetal abnormalities in singleton and multiples: medical, ethics and legal aspects

10.15 - 10.30

M. Cuttini (Italy)
Ethics from an European perspective

09.30 - 10.30

0.2/0.3 BERLIN/COPENHAGEN
PARALLEL 4:
PRETERM BIRTH

Chairpersons: L. Zimmermann (The Netherlands); G. Buonocore (Italy)

09.30 - 10.00

G. Buonocore (Italy)
Oxidative stress in perinatal period

10.00 - 10.30

Angela Kribs (Germany)
Gentle transition of the preterm infant

09.30 - 10.30

0.11 PRESS ROOM
PARALLEL 5:
SAT PAR-NEO5) OPTIMISING NUTRITION TO PRETERM INFANTS

Chairperson: M. Benders (the Netherlands)

09.30 - 09.50

V. Carnielli (Italy) 
Lipids in Perinatal Nutrition

09.50 - 10.10

H. Van Goudoever (The Netherlands)
Safety and efficacy of human donor Milk

10.10 - 10.30

M. Benders (The Netherlands) 
Neonatal nutrition, ROP, and brain damage / brain growth

10.30 - 11.00

COFFEE BREAK AND POSTER VIEWING
TOPICS:
ORGANIZATION AND NETWORK and LABOUR

11.00 - 12.00

AUDITORIUM 1
SEMI-PLENARY 1:
DPL-OB3) INTRAPARTUM FETAL MONITORING

Chairpersons: G. H. A. Visser (The Netherlands); A. Athanasiadis (Greece)

11.00 - 11.15

D. Ayres-de-Campos (Portugal)         
The new FIGO guidelines on intrapartum fetal monitoring

11.15 - 11.30

A. Ugwumadu (UK)
Clinical management in cases of suspected fetal hypoxia/acidosis

11.30 - 11.45

A. Kwee (The Netherlands)
Does CTG+ST improve clinical outcome?

11.45 - 12.00

G. H. A. Visser (The Netherlands)
The clinical relevance of adjunctive technologies

11.00 - 12.00

AUDITORIUM 2
SEMI-PLENARY 2:
DPL-NEO2) PAIN AND STRESS IN THE NICU

Chairpersons: R. Carbajal (France); D. Tibboel (Netherlands)

11.00 - 11.30

R. Carbajal (France)
The burden of pain and stress in the NICU 

11.30 - 12.00

D. Tibboel (Netherlands)
Pain assessment in sick neonates and newborns

12.00 - 12.30

AUDITORIUM 1 + 2
PLENARY:
PLM6) KEYNOTE LECTURE OF FUTURE PRESIDENT

Chairperson: U. Simeoni (Switzerland)

M. Hod (Israel)
Connecting Maternal Medicine to Fetal Medicine- merging of the Perinatal hypotheses

12.30 - 13.00

CLOSING CEREMONY

A. Mikhailov (Russia)
Invitation to St. Petersburg